Patent Court to rule Sanofi-Aventis's Plavix Patent soon

Published: 2007-10-17 07:00:00

Updated: 2007-10-17 07:00:00

The local patent court will affirm the validity and enforceability of Sanofi-Aventis's Plavix Patent on clopidogrel bisulfate early next month, according to the market sources.

Clopidogrel is the active ingredient in Plavix, the company's treatment for coronary artery disease. The court's deci...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK